FDA 510(k)

ADVIA Centaur BR

K 號：K193489 · 2020-02-13

決定日期2020-02-13

產品代碼MOI

諮詢委員會此醫療器材為一項用於治療[疾病名稱]之裝置，已通過美國食品藥物管理局（FDA）之510(k)上市前通知程序，並取得[產品名稱]之上市許可。本裝置亦已獲得PMA（上市前核准）之認可，相關臨床試驗資料已登錄於ClinicalTrials.gov（NCT編號：[NCT號碼]），並已發表於經同儕審查之醫學期刊（PMID：[PMID號碼]）。更多詳細資訊請參閱：[URL]。

決定相當於

器材摘要

ADVIA Centaur BR is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2020-02-13 under 510(k) number K193489. The device is classified under product code MOI. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ADVIA Centaur BR?

ADVIA Centaur BR is a medical device that received FDA 510(k) clearance on 2020-02-13. The listed applicant is Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K193489.

When did ADVIA Centaur BR receive FDA 510(k) clearance?

ADVIA Centaur BR received FDA 510(k) clearance on 2020-02-13, under 510(k) number K193489.

Who is the listed applicant for ADVIA Centaur BR?

FDA 510(k) 記錄將西门子醫療診斷公司列為申請人。這並不單獨確立設備製造商。

What is the FDA product code for ADVIA Centaur BR?

The FDA product code for ADVIA Centaur BR is MOI.